Meeting patient preferences regarding adverse drug reaction (ADR) information for duration, time to onset and self-management strategies: an observational study

dc.rights.license	CC-BY-NC-ND
dc.contributor.advisor	Boer, A. de
dc.contributor.author	Ophoff, Marlous
dc.date.accessioned	2023-05-10T23:00:55Z
dc.date.available	2023-05-10T23:00:55Z
dc.date.issued	2023
dc.identifier.uri	https://studenttheses.uu.nl/handle/20.500.12932/43873
dc.description.sponsorship	Utrecht University
dc.language.iso	EN
dc.subject	First, this study aimed to assess whether the current ADR information provision sources in the Netherlands provide information in line with the domains that patients prefer. Second, if data collected by pharmacovigilance centres can provide information on the domains 'duration', 'time to onset', and 'self-management strategies' was examined for the ADRs injection site reactions, infections and skin reactions in adalimumab and etanercept users.
dc.title	Meeting patient preferences regarding adverse drug reaction (ADR) information for duration, time to onset and self-management strategies: an observational study
dc.type.content	Master Thesis
dc.rights.accessrights	Open Access
dc.subject.courseuu	Farmacie
dc.thesis.id	5617